One of the main goals of Life4me+ — is to prevent new cases of HIV and other STIs, hepatitis C and tuberculosis.

The app helps to establish anonym communication between physicians and HIV-positive people. It allows you to conveniently organize your medication intake timetable and set concealed and personalized reminders.

Hornet's New Ad Aiming to LGBTQ People Living With HIV Promotes Inclusive Dating

14 July 2017 16:02

Check this Hornet’s new beautiful ad, written by a guy living with HIV, about how dating between HIV-negative and HIV-positive persons could be in the modern world.

The video, which is part of the “Making Connections” series, is entitled “Making Connections That Can Change The World” and features two HIV-positive actors having a conversation on the app. One is addressed by the other with the mild phrase, “Poz here too” and that starts an online chat about dating, disclosure, and life with HIV. It’s one of the first times HIV has been integrated into marketing as a part of the everyday lives of gay men, as opposed to the primary focus of marketing. It is a groundbreaking step toward shifting the narrative of what it means to live with HIV today.

Watch this ad on Youtube.

HIV-positive men regularly report experiencing stigmatizing messages on various dating apps and often being stigmatized in real life. Hornet marketing video shows an example of some of the advantages of HIV-positive men making heartwarming connections and stay free from stigma and discrimination.


Latest News

DIY faecal transplants carry risks including HIV and hepatitis

Faecal transplants have been used in medical settings to tackle superbugs, but following YouTube videos at home is too risky, say researchers.

16 February 15:30

Gilead's total revenues were $26.1 billion in 2017

For the fourth quarter 2017, Gilead Sciences total revenues were $5.9 billion. For the full year 2017, total revenues were $26.1 billion. HIV and HBV product sales for the full year 2017 were $14.2 billion. Genvoya represents the most successful HIV launch in the U.S. and ...

16 February 09:31

Key vaginal bacteria identified that increase HIV risk in women

Women's risk of HIV significantly associated with key bacteria and their abundance in the vagina.

15 February 16:35

Experimental Drug Kills Flu Virus in a Single Day

Shionogi developed baloxavir marboxil by leveraging discoveries made in anti-HIV drugs, targeting a different kind of enzyme and preventing cells from susceptibility to virus infection in the first place.

15 February 13:27